Flipping the mJOA: Clinical utility of the modified Japanese Orthopaedic Association score as a tool for detecting degenerative cervical myelopathy
Brain and Spine · 2024 · 4 · 102853
DOI: 10.1016/j.bas.2024.102853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Spine, 2024. Verfasst von Caroline Treanor und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Neurosurgical Centre, Beaumont Hospital, Dublin 9, Ireland. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Excellence, Society of Transnational Academic Researchers Scholars Network, RCSI Royal College of Surgeons in Ireland Dublin.
Abstract (Originalsprache)
Introduction
People with Degenerative Cervical Myelopathy (DCM) often experience diagnostic delay. This could lead to poorer outcomes, including disability. Research question: Does the modified Japanese Orthopaedic Association scale (mJOA) have clinical utility as an early detection tool for possible DCM? Materials and methods: This is a prospective study of consecutive adult patients, referred to a National Neurosurgical Centre with a neck problem. Assessing clinicians undertook standard clinical examination and calculated the mJOA score. A consultant radiologist independently reported radiological findings, after which the assessing clinician determined the diagnosis. The sensitivity and specificity of mJOA for DCM at various cut-points was statistically analysed using Receiver Operating Characteristics (ROC) curves.
Results
Of 201 patients (98 male, mean age 52.6 ± 13y) assessed over 13 months, 21 were diagnosed with DCM (prevalence 10.4%). Fifteen (71.4%) had a mJOA score classifying disease severity as mild, 4/21 (19%) had moderate disease and two (9.5%) had severe disease. A mJOA score ≤17 (cutpoint ≥1) showed sensitivity of 95% and specificity of 71% for the clinical diagnosis of DCM. mJOA score ≤16 (cutpoint ≥2) had sensitivity of 62% and specificity of 90%. The ROC area under the curve was 0.885 (95% confidence interval: 0.82 to 0.95). 87% of patients were correctly classified. Discussion and conclusion: mJOA score ≤16 is 90% specific for a subsequent diagnosis of DCM in people with neck problems and has potential to be used as an early detection tool. Further research is needed to replicate these findings and establish feasibility and acceptability in primary care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Neurosurgical Centre, Beaumont Hospital, Dublin 9, Ireland.
- School of Physiotherapy, Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences, Dublin 2, Ireland.
- Department of Clinical Neuroscience, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland.
Förderung
- National Institute for Health and Care Excellence
- Society of Transnational Academic Researchers Scholars Network
- RCSI Royal College of Surgeons in Ireland Dublin
Zitieren
APA
Treanor, C., Gallagher, C., Lenehan, W., Gantly, H., Bolger, C., & Malone, A. (2024). Flipping the mJOA: Clinical utility of the modified Japanese Orthopaedic Association score as a tool for detecting degenerative cervical myelopathy. Brain and Spine, 4, 102853. https://doi.org/10.1016/j.bas.2024.102853
Vancouver
Treanor C, Gallagher C, Lenehan W, Gantly H, Bolger C, Malone A. Flipping the mJOA: Clinical utility of the modified Japanese Orthopaedic Association score as a tool for detecting degenerative cervical myelopathy. Brain and Spine. 2024;4:102853. doi:10.1016/j.bas.2024.102853
BibTeX
@article{Treanor2024,
author = {Treanor, Caroline and Gallagher, Conor and Lenehan, Warren and Gantly, Hannah and Bolger, Ciaran and Malone, Ailish},
title = {Flipping the mJOA: Clinical utility of the modified Japanese Orthopaedic Association score as a tool for detecting degenerative cervical myelopathy},
journal = {Brain and Spine},
year = {2024},
volume = {4},
pages = {102853},
doi = {10.1016/j.bas.2024.102853}
}
EUVIMED